BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15952091)

  • 41. An Exotic Visitor.
    Gupta RS; Wilke K; Vieth M
    Dtsch Arztebl Int; 2018 Feb; 115(8):123. PubMed ID: 29526183
    [No Abstract]   [Full Text] [Related]  

  • 42. Light and electron microscopic studies on Schistosoma mansoni Granulomas of mouse livers following treatment with praziquantel.
    Mehlhorn H; Frenkel JK; Andrews P; Thomas H
    Tropenmed Parasitol; 1982 Dec; 33(4):229-39. PubMed ID: 6891845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Schistosomiasis control program in the state of Minas Gerais in Brazil.
    Drummond SC; Pereira SR; Silva LC; Antunes CM; Lambertucci JR
    Mem Inst Oswaldo Cruz; 2010 Jul; 105(4):519-23. PubMed ID: 20721502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapeutic evaluation of praziquantel (Embay 8440) in human infection due to S. mansoni].
    de Carvalho SA; Amato Neto V; Zeitune JM; Goldbaum M; Castilho EA; Grossman RM
    Rev Inst Med Trop Sao Paulo; 1984; 26(1):51-9. PubMed ID: 6463521
    [No Abstract]   [Full Text] [Related]  

  • 45. Praziquantel: a new schistosomicide against Schistosoma mansoni.
    McMahon JE
    Arzneimittelforschung; 1981; 31(3a):592-4. PubMed ID: 7195252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidental hepatic schistosomiasis in a liver transplant recipient.
    Ariza-Heredia E; Razonable RR
    Transpl Infect Dis; 2012 Feb; 14(1):75-8. PubMed ID: 21504529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of hepatosplenic Schistosomiasis mansoni with praziquantel. Preliminary report on tolerance and efficacy.
    Coutinho A; Domingues AL; Neves J; Almeida ST
    Arzneimittelforschung; 1983; 33(5):787-91. PubMed ID: 6683560
    [No Abstract]   [Full Text] [Related]  

  • 48. Intracranial Schistosoma mekongi infection.
    Carmody D; Nolan C; Allcutt D
    Ir Med J; 2008; 101(10):315. PubMed ID: 19205144
    [No Abstract]   [Full Text] [Related]  

  • 49. Replacing oxamniquine by praziquantel against Schistosoma mansoni infection in a rural community from the sugar-cane zone of Northeast Brazil: an epidemiological follow-up.
    Beck L; Favre TC; Pieri OS; Zani LC; Domas GG; Barbosa CS
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():165-7. PubMed ID: 11586444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute colonic obstruction due to schistosomiasis in conjunction with ingestion of mangos.
    Nicodemus P; Congdon R
    Trop Doct; 2001 Oct; 31(4):234-5. PubMed ID: 11676071
    [No Abstract]   [Full Text] [Related]  

  • 51. Developing novel strategies to prevent parasitic infections.
    Staines HM; Croft SL; Horrocks PD
    Expert Rev Anti Infect Ther; 2011 Jul; 9(7):783-5. PubMed ID: 21810050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Schistosomiasis in non-endemic countries.
    Coltart C; Whitty CJ
    Clin Med (Lond); 2015 Feb; 15(1):67-9. PubMed ID: 25650202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary observations on the treatment of Schistosomiasis mansoni with praziquantel in Kenya.
    Smith DH; Highton RB; Roberts JM
    Arzneimittelforschung; 1981; 31(3a):594-6. PubMed ID: 7195253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bilharziasis cutanea tarda: a rare manifestation of schistosomiasis and ectopic presentation of late cutaneous disease.
    Mapelli ET; Cerri A; Coassini A; Bombonato C; Menni S
    G Ital Dermatol Venereol; 2014 Apr; 149(2):271-2. PubMed ID: 24819648
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevalence of Schistosomes and Soil-Transmitted Helminths and Morbidity Associated with Schistosomiasis among Adult Population in Lake Victoria Basin, Tanzania.
    Siza JE; Kaatano GM; Chai JY; Eom KS; Rim HJ; Yong TS; Min DY; Chang SY; Ko Y; Changalucha JM
    Korean J Parasitol; 2015 Oct; 53(5):525-33. PubMed ID: 26537031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of praziquantel against the South African strains of Schistosoma haematobium and S. mansoni.
    Schutte CH; Osman Y; Van Deventer JM; Mosese G
    S Afr Med J; 1983 Jul; 64(1):7-10. PubMed ID: 6344270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Schistosomiasis: Drugs used and treatment strategies.
    Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
    Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment.
    Pica-Mattoccia L; Cioli D
    Int J Parasitol; 2004 Mar; 34(4):527-33. PubMed ID: 15013742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
    Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
    Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.